ancestim: Clinical Trials

2 trials of ancestim, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow ancestim: new trials by email Literature Review of ancestim trials Research Report on ancestim

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders
Recombinant-methionyl human stem cell factor - Hemoglobin SC Disease, Sickle Cell Anemia
Phase 1CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)502000-03-012008-03-04
Stem Cell Factor Medication for Aplastic Anemia
Recombinant Methionyl Human Stem Cell Factor (r-metHuSCF) - Aplastic Anemia, Pancytopenia
Phase 1CompletedNational Heart, Lung, and Blood Institute (NHLBI)401993-10-012008-03-04

Conditions studied

Anemia, Aplastic (1)  ·  Anemia, Sickle Cell (1)  ·  Bone Marrow Failure Disorders (1)  ·  Hemoglobin SC Disease (1)  ·  Pancytopenia (1)  ·  Vaso-Occlusive Crises (1)  ·  beta-Thalassemia (1)

Sponsors

National Heart, Lung, and Blood Institute (NHLBI) (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)

Countries

United States (2)